Format

Send to

Choose Destination
Clin Chem Lab Med. 2002 Sep;40(9):903-10.

The ELISPOT assay: an easily transferable method for measuring cellular responses and identifying T cell epitopes.

Author information

1
AIDS Research Unit, National Institute for Communicable Diseases, Johannesburg, South Africa.

Abstract

Characterization of human leukocyte antigen (HLA) class I restricted epitopes derived from viral pathogens is imperative for formulating therapeutic interventions, as well as for vaccine design and monitoring. Sensitive, easy and cost-effective assays that measure the frequency of antigen-specific T lymphocytes are crucial for evaluating and improving vaccines and therapies. This paper reviews the ELISPOT technique that allows for quantifying HIV-specific T lymphocytes at the single cell level from peripheral blood by detection of antigen-induced cytokine secretion. The assay can be used successfully to quantify T cell immune responses in humans infected with different pathogens and to assess T cell immunogenicity of vaccines in phase I/II and III clinical trials. This review focuses on the ELISPOT methodology and discusses how it can be standardized and potentially used by multiple international laboratories attached to clinical trial sites.

PMID:
12435107
DOI:
10.1515/CCLM.2002.159
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Sheridan PubFactory
Loading ...
Support Center